These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6280603)

  • 1. Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
    Beggs WH; Sarosi GA
    Antimicrob Agents Chemother; 1982 Feb; 21(2):355-7. PubMed ID: 6280603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
    Mary C; Goudard M; Blancard A; Quilici M; Regli P
    Ann Biol Clin (Paris); 1989; 47(9):546-9. PubMed ID: 2558599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F; Raab W
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
    Guinet R
    Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
    Beggs WH; Andrews FA; Sarosi GA
    Chemotherapy; 1981; 27(4):247-51. PubMed ID: 7195793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of serum 5-fluorocytosine concentrations in the presence of ketoconazole.
    Roselle GA; Warth P
    J Antimicrob Chemother; 1983 Aug; 12(2):189-92. PubMed ID: 6311787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):495-8. PubMed ID: 6294764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of antifungal agents against yeast species.
    Bergan T; Vangdal M
    Chemotherapy; 1983; 29(2):104-10. PubMed ID: 6301773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG; McGlohn MS
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.
    Moody MR; Young VM; Morris MJ; Schimpff SC
    Antimicrob Agents Chemother; 1980 May; 17(5):871-5. PubMed ID: 6249197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.
    Corrado ML; Kramer M; Cummings M; Eng RH
    Sabouraudia; 1982 Jun; 20(2):109-13. PubMed ID: 6287653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antifungal susceptibility of emerging yeast pathogens].
    García-Martos P; Domínguez I; Marín P; García-Agudo R; Aoufi S; Mira J
    Enferm Infecc Microbiol Clin; 2001; 19(6):249-56. PubMed ID: 11440661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
    Rumler W; Heins S; Heins J
    Mykosen; 1984 Sep; 27(9):436-42. PubMed ID: 6390193
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid microdilution-colorimetric assay for yeast susceptibility to fluorocytosine.
    Fisher BD; Armstrong D
    Antimicrob Agents Chemother; 1977 Nov; 12(5):614-7. PubMed ID: 335966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S; Wagner G; Espinel-Ingroff E; Davis BA
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
    Perfect JR; Durack DT
    J Infect Dis; 1982 Sep; 146(3):429-35. PubMed ID: 6286799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
    Still JM; Law EJ; Belcher KE; Spencer SA
    Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Synergism between 5-fluorocytosine and polyene antibiotics.
    Polak A
    Pathol Microbiol (Basel); 1975; 42(4):234-5. PubMed ID: 778764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.